Cyclic bridgehead ether DGAT1 inhibitors

• 收藏
• 分享

专利权人:

Novartis AG

发明人:

Chen, Xin,Ding, Yiping,Duvadie, Rohit,Gai, Yu,Harrison, Tyler,Liu, Qian,Larrow, Jay,Mao, Justin Yik Ching,Patel, Sejal,Ye, Jiong,Zecri, Frederic,Zheng, Xuchun,Zheng, Rui,Zhou, Yizong

申请号：

AU2013254307

公开号：

AU2013254307A1

申请日:

2013.04.25

申请国别(地区):

AU

年份:

2014

代理人:

摘要：

The invention relates to compounds of formula (I): (I) useful for treating disorders mediated by acyl coA-diacylglycerol acyl transferase 1 (DGAT1), e.g. metabolic disorders. The invention also provides methods of treating such disorders, and compounds and compositions etc. for their treatment.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/